A therapeutic antibody (bispecific nanobody) developed by researchers at Georgia State University and collaborators neutralized all three highly pathogenic human coronaviruses (SARS-CoV, SARS-CoV-2 and MERS-CoV) and protected animals from viral infections, according to a study published in the journal ACS Nano.
Therapeutic antibody protects against all three pathogenic human coronaviruses
Researchers at Georgia State University developed a bispecific nanobody therapeutic antibody that neutralizes all three pathogenic human coronaviruses (SARS-CoV, SARS-CoV-2, and MERS-CoV) and protected animals from infection in laboratory studies. This scientific breakthrough has no direct connection to Iran but represents international medical research progress.
👥 Key Players
📰 What Happened
Researchers developed a bispecific nanobody (a type of therapeutic antibody) that can neutralize all three major pathogenic human coronaviruses: SARS-CoV, SARS-CoV-2, and MERS-CoV. Laboratory animal studies demonstrated the antibody protected against viral infections. This represents a potential breakthrough in developing broad-spectrum coronavirus treatments.
- The therapeutic targets three distinct coronaviruses known to cause severe human disease
- Animal model protection was demonstrated in laboratory conditions
- The approach uses a 'bispecific nanobody' design, a relatively newer antibody engineering technique
💡 Why It Matters
📚 Background
Coronaviruses have caused three major human disease outbreaks: SARS (2003), MERS (2012), and COVID-19 (2019-present). Developing treatments that work against multiple coronavirus strains is valuable because it could provide protection against both current and future coronavirus variants or new coronavirus species.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%